investor.frx.comInvestors - Allergan

’); Global Sites Countries Country Sites Countries Country Sites Argentina Argentina Site Australia Australia Site Austria Austria Site Bahrain Bangladesh Barbados Belgium Belgium Site Bolivia Brazil Brazil Site Canada Canada Site Chile Chile Site China (Mainland) China (Mainland) Site Colombia Colombia Site Costa Rica Czech Republic Czech Republic Site Denmark Dominican Republic Ecuador Egypt El Salvador Finland France France Site Germany Germany Site Greece Guatemala Honduras Hong Kong (China) Hungary India India Site Indonesia Ireland Ireland Site Israel Italy Italy Site Jamaica Japan Japan Site Jordan Korea Korea Site Kuwait Lebanon Malaysia Mexico Mexico Site Netherlands Netherlands Site New Zealand New Zealand Site Norway Pakistan Palestine Panama Peru Philippines Poland Poland Site Portugal Portugal Site Puerto Rico Romania Russia Russia Site Saudi Arabia Serbia Serbia Site Singapore Slovakia South Africa South Africa Site Spain Spain Site Sri Lanka Sweden Sweden Site Switzerland Switzerland Site Taiwan (China) Taiwan (China) Site Thailand Trinidad & Tobago Turkey Turkey Site Ukraine United Arab Emirates United Kingdom United Kingdom Site United States United States Site Uruguay Venezuela Vietnam Yemen Allergan Home Global / USA Contact Investors Events & Presentations Corporate & Financial Information Corporate Information: Executives & Leadership Corporate Governance Committee Composition Committee Charters Acquisition of Allergan by AbbVie Financials: Annual Reports Quarterly Results SEC Filings Insider Transactions Proxy Materials Shareholder Resources Shareholder Services & Investor Kit Information Request Form Email Alerts Dividends Investor FAQ Stock information Stock Information Historic Stock Look-Up Analyst Coverage Investment Calculator Menu Close Global / USA Home Products Key Therapeutic Areas Central Nervous System Eye Care Gastroenterology Medical Aesthetics Patient Assistance Programs View All Products About About Allergan About Allergan News Executive Leadership Business Development Supplier Relations Patent Notices Media Resources R&D R&D Pipeline Clinical Trials Innovation Pre-Approval Access Responsibility Responsibility at Allergan Community Environmental & Sustainability Social Contract Patient Safety & Product Quality Healthcare Provider Partnerships & Payments Alliance Advocacy Support Public Policy California Supply Chain Disclosure Investors Media Patients Providers Careers Contact Central Nervous System Key Products View All Central Nervous System Products BOTOX® (onabotulinumtoxinA) NAMZARIC® (memantine hydrochloride extended-release and donepezil hydrochloride) capsules, for oral use UBRELVY™ (ubrogepant) tablets, for oral use VRAYLAR® (cariprazine) capsules, for oral use Eye Care Key Products View All Eye Care Products LUMIGAN® 0.01% (bimatoprost ophthalmic solution 0.01%) OZURDEX® (dexamethasone intravitreal implant) 0.7 mg REFRESH® Portfolio of Consumer Eye Care Products Gastroenterology Key Products View All Gastroenterology Products LINZESS® (linaclotide) capsules, for oral use VIBERZI® (eluxadoline) tablets, for oral use, CIV ZENPEP® (pancrelipase) delayed release capsules Medical Aesthetics Key Products View All Medical Aesthetics Products BOTOX® Cosmetic (onabotulinumtoxinA) COOLSCULPTING® JUVÉDERM® Ultra SkinMedica® Investors Investors Events & Presentations Corporate & Financial Information Corporate Information: Executives & Leadership Corporate Governance Committee Composition Committee Charters Acquisition of Allergan by AbbVie Financials: Annual Reports Quarterly Results SEC Filings Insider Transactions Proxy Materials Shareholder Resources Shareholder Services & Investor Kit Information Request Form Email Alerts Dividends Investor FAQ Stock information Stock Information Stock Information Historic Stock Look-Up Analyst Coverage Investment Calculator Media Media Company Profile Executive Bios & Photos images Videos Patients Patients Providers Providers Medical Information Request Careers Careers Search Careers Investor At Allergan, we’re committed to developing life-enhancing innovations. We market a portfolio of leading brands and best-in-class products focused on four key therapeutic areas including medical aesthetics, eye care, central nervous system and gastroenterology. As part of our approach to delivering innovation for better patient care, we have built one of the broadest pharmaceutical and device research and development pipelines in the industry. View our R&D Pipeline Acquisition of Allergan plc by AbbVie Inc. Latest Investor News View All Investor News Announcement under the Irish Takeover Rules: Relevant Securities in Issue - February 14, 2020 Announcement under Rule 8.1(a) of the Irish Takeover Rules: Dealings by Offerors, Offerees or Parties Acting in Concert With Them for Themselves or for Discretionary Clients Allergan Reports Fourth Quarter and Full-Year 2019 Financial Results BOTOX® Cosmetic (onabotulinumtoxinA) Launches Be The Difference Philanthropic Program Most Recent Financials Earnings Latest Earnings Press Release Latest form 10-Q PDF Proxy Materials 2018 Form 10-K PDF 2018 Irish Annual Report PDF 2019 Proxy Statement PDF 2019 Proxy Card PDF Supplemental Deck April 2019 PDF Shareholder Letter April 2019 PDF Annual Report 2019 Form 10-K PDF SEC Filings Latest SEC Filings Recent Events View All Events Corporate Conference Call Q2 2019 Allergan plc Earnings Release Go To Webcast Conference Presentation Allergan plc at the Jefferies 2019 Healthcare Conference Go To Webcast Conference Presentation Allergan plc at the Bernstein 35th Annual Strategic Decisions Conference Go To Webcast Conference Presentation Allergan plc at the Bank of America Merrill Lynch 2019 Health Care Conference Go To Webcast Earnings Conference Call Q1 2019 Allergan plc Earnings Conference Call About Allergan All Products Contact Compliance Privacy Terms California Privacy Sitemap Copyright © 2020 Allergan X This website uses cookies and other technologies to personalize content and to show you more personalized ads (for example, Google Ads and Facebook) on this and other websites, as well as provide you with social media features on this website (such as, Facebook, Twitter, LinkedIn). By clicking Accept” you understand that you are directing Allergan to disclose your personal information, including internet tracking data (like cookies and the IP address you used to access this website), to these third parties for the purposes stated above. You can still use this website if you do not click Accept,” but your experience may be different. For more information, including information on the categories of third parties to whom we disclose your personal information, please refer to our global privacy policies, available at www.allergan.com/privacy . For additional options please check your browser’s settings....